Butabarbital and olopatadine intranasal equally enhance sedation. Avoid or Use Alternate Drug. Coadministration increases possibility of CNS depression, which can cause additive impairment of psychomotor general performance and induce daytime impairment. butabarbital will reduce the level or impact of sufentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/I... https://kurtn924kmo8.luwebs.com/profile